Nubeqa success in Phase III prostate cancer study

31st January 2020 Uncategorised 0

“A positive trend in overall survival” had been seen in a trial, with an interim analysis demonstrating a 29% reduction in the risk of death for Nubeqa.

More: Nubeqa success in Phase III prostate cancer study
Source: News